No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group

Castano-Bonilla, T; Barragan, E; Sargas, C; Sanz, A; Algarra, L; Herrera-Puente, P; Garcia-Boyero, R; Barrios, M; Martinez-Cuadron, D; Rodriguez-Veiga, R; Boluda, B; Gil, C; Serrano-Lopez, J; Martinez-Lopez, J; Sayas-Lloris, MJ; Olave, MT; Riaza-Grau, R; Bernal-Del...